安徽丰原药业股份有限公司2025年半年度报告摘要

Group 1 - The company did not distribute cash dividends, issue bonus shares, or increase capital from reserves during the reporting period [3] - The company did not experience any changes in its controlling shareholder or actual controller during the reporting period [5] - There were no preferred shareholders or related holdings reported during the reporting period [5] Group 2 - All directors attended the board meeting to review the report [2] - The report does not require retrospective adjustments or restatements of previous accounting data [4] - There are no significant matters reported during the period [5]